Lacosamide Tablet, Film Coated
Product Images NDC 68462-681

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 68462-681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc. Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-label (100mg Label)

Lacosamide Tablets, USP 100 mg film-coated tablets label by Glenmark Pharmaceuticals Inc. USA. The label indicates a package of 60 tablets. It includes storage instructions, dosage guidance, manufacturer details, and a barcode.*

FDA Label Image

150mg-label (150mg Label)

Lacosamide Tablets, USP 150 mg film-coated tablets packaging label from Glenmark Pharmaceuticals Inc. USA. The label shows a 60-tablet count bottle with dosage instructions, storage conditions, and manufacturer details including NDC 68462-680-60. The label includes a barcode and instructions to dispense the Medication Guide separately.*

FDA Label Image

200mg-label (200mg Label)

Lacosamide Tablets, USP 200 mg film-coated oral tablets packaging label showing the Glenmark Pharmaceuticals Inc. USA branding. The label indicates a bottle containing 60 tablets, with instructions to dispense the medication guide separately. Storage conditions and manufacturer details are also included, along with the NDC number 68462-681-60 and a barcode.*

FDA Label Image

50mg-label (50mg Label)

Label for Lacosamide Tablets, USP 50 mg oral film-coated tablets by Glenmark Pharmaceuticals Inc. USA. The label indicates 60 tablets per container with instructions for the pharmacist to dispense a Medication Guide separately. Storage information and contact details for Glenmark Pharmaceuticals USA are also displayed.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of lacosamide, depicted as a 2D molecular diagram showing atoms and bonds characteristic of the compound.*

FDA Label Image

Figure1 (Figure1)

A bar chart showing median percent seizure reduction from baseline in three clinical studies comparing placebo versus different doses of lacosamide. The graph displays data from Study 2, Study 3, and Study 4, with lacosamide doses ranging from 200 mg to 600 mg per day. Statistically significant improvements versus placebo are indicated by asterisks.*

FDA Label Image

Figure2 (Figure2)

A cumulative responder rate curve graph showing improvement and worsening responder rates by percent of patients for placebo and lacosamide doses of 200 mg/day, 400 mg/day, and 600 mg/day. The graph plots responder rate (equal to or greater improvement vs worsening) on the vertical axis and percent of patients on the horizontal axis, comparing therapeutic response across these groups.*

FDA Label Image

Glenmark-logo (Glenmark Logo)

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.